RMEI Continuing Medical Education Neuroscience

Neuroscience CE Activities

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CE Credit(s)

Spinal Muscular Atrophy: An Interprofessional Approach

0.75 CE Credit(s)

Realizing the Promise of Interprofessional Care and Collaboration in Multiple Sclerosis

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

CE Credit Expired

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience
Decision Support Aid

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience, Psychiatry
Decision Support Aid

LATEST NEUROSCIENCE ARTICLES

Latest Neuroscience Articles

Self-Neglect in Older People — A Clinical, Social, and Ethical Dilemma June 28, 2025
Navigating cases of potential self-neglect is complicated for older adults and for the family members, clinicians, and social and legal services professionals involved in ensuring their well-being.
Kristin Lees Haggerty, David B. Reuben
Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation June 26, 2025
In a randomized trial, the routine use of cerebral embolic protection during TAVI did not reduce the incidence of stroke within 72 hours or before discharge from the hospital (if discharge occurred sooner).
Rajesh K. Kharbanda, James Kennedy, Zahra Jamal, Matthew Dodd, Richard Evans, Kiran K. Bal, Alexander D. Perkins, Daniel J. Blackman, David Hildick-Smith, Adrian P. Banning, Andreas Baumbach, Peter Ludman, Stephen Palmer, Rodney H. Stables, Robert Henderson, Clare Appleby, James Cotton, Nick Curzen, Muhiddin Ozkor, Jonathan Byrne, Rajesh Aggarwal, Rajiv Das, Sagar Doshi, Stuart Watkins, Douglas F. Muir, Richard Anderson, Saqib Chowdhary, Richard Varcoe, Stephen Dorman, Sam Firoozi, Raj Chelliah, Colum Owens, Simon Redwood, Bernard Prendergast, Javaid Iqbal, Karim Ratib, Ciprian Dospinescu, Venkatesan Suresh, Nicholas Cruden, Thirumaran Rajathurai, Iqbal S. Malik, Andrew Wiper, Charis Costopoulos, Ayush Khurana, Amerjeet Banning, Tim Clayton, the BHF PROTECT-TAVI Investigators*
Gene Therapy for Infantile-Onset Pompe’s Disease June 26, 2025
Pompe’s disease is a lysosomal storage disorder that manifests as a metabolic myopathy and is almost invariably associated with severe and progressive physical disability and premature death, particularly among patients with infantile-onset disease. It is caused by a genetic deficiency of acid α-glucosidase (GAA), a lysosomal enzyme that converts glycogen...
Giancarlo Parenti, Nicola Brunetti-Pierri

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021